- Home
- MURA vs LDTC Comparison
MURA vs LDTC Comparison
Compare MURA & LDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MURA
- LDTC
- Stock Information
- Founded
- MURA 2013
- LDTC 2007
- Country
- MURA Ireland
- LDTC Canada
- Employees
- MURA N/A
- LDTC N/A
- Industry
- MURA
- LDTC Blank Checks
- Sector
- MURA
- LDTC Finance
- Exchange
- MURA Nasdaq
- LDTC Nasdaq
- Market Cap
- MURA 45.8M
- LDTC 37.5M
- IPO Year
- MURA N/A
- LDTC N/A
- Fundamental
- Price
- MURA $2.64
- LDTC $0.32
- Analyst Decision
- MURA Strong Buy
- LDTC Buy
- Analyst Count
- MURA 4
- LDTC 2
- Target Price
- MURA $13.00
- LDTC $3.00
- AVG Volume (30 Days)
- MURA 190.3K
- LDTC 298.7K
- Earning Date
- MURA 05-14-2025
- LDTC 05-14-2025
- Dividend Yield
- MURA N/A
- LDTC N/A
- EPS Growth
- MURA N/A
- LDTC N/A
- EPS
- MURA N/A
- LDTC N/A
- Revenue
- MURA N/A
- LDTC $413,610.00
- Revenue This Year
- MURA $34.35
- LDTC $906.25
- Revenue Next Year
- MURA N/A
- LDTC $149.88
- P/E Ratio
- MURA N/A
- LDTC N/A
- Revenue Growth
- MURA N/A
- LDTC 141.86
- 52 Week Low
- MURA $0.95
- LDTC $0.22
- 52 Week High
- MURA $4.74
- LDTC $2.75
- Technical
- Relative Strength Index (RSI)
- MURA 51.80
- LDTC 40.91
- Support Level
- MURA $2.56
- LDTC $0.29
- Resistance Level
- MURA $2.72
- LDTC $0.33
- Average True Range (ATR)
- MURA 0.14
- LDTC 0.05
- MACD
- MURA -0.02
- LDTC -0.02
- Stochastic Oscillator
- MURA 33.33
- LDTC 8.65
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
About LDTC LeddarTech Holdings Inc.
LeddarTech Holdings Inc is a company that develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. Its automotive-grade software applies AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for decision-making and safer navigation. The company generates the majority of its revenue from France, Canada, and the United states.